| pubmed-article:12297576 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:12297576 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
| pubmed-article:12297576 | lifeskim:mentions | umls-concept:C0087111 | lld:lifeskim |
| pubmed-article:12297576 | lifeskim:mentions | umls-concept:C0018787 | lld:lifeskim |
| pubmed-article:12297576 | lifeskim:mentions | umls-concept:C0026259 | lld:lifeskim |
| pubmed-article:12297576 | lifeskim:mentions | umls-concept:C0879626 | lld:lifeskim |
| pubmed-article:12297576 | lifeskim:mentions | umls-concept:C0332281 | lld:lifeskim |
| pubmed-article:12297576 | lifeskim:mentions | umls-concept:C2349943 | lld:lifeskim |
| pubmed-article:12297576 | lifeskim:mentions | umls-concept:C0282248 | lld:lifeskim |
| pubmed-article:12297576 | pubmed:issue | 6 | lld:pubmed |
| pubmed-article:12297576 | pubmed:dateCreated | 2002-9-25 | lld:pubmed |
| pubmed-article:12297576 | pubmed:abstractText | Mitoxantrone (MITO) is associated with dose-related cardiotoxicity when administered concomitantly with other cytotoxic agents with or without radiotherapy for leukemia and solid tumors. | lld:pubmed |
| pubmed-article:12297576 | pubmed:language | eng | lld:pubmed |
| pubmed-article:12297576 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12297576 | pubmed:citationSubset | AIM | lld:pubmed |
| pubmed-article:12297576 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12297576 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:12297576 | pubmed:month | Sep | lld:pubmed |
| pubmed-article:12297576 | pubmed:issn | 0028-3878 | lld:pubmed |
| pubmed-article:12297576 | pubmed:author | pubmed-author:GonsetteR ERE | lld:pubmed |
| pubmed-article:12297576 | pubmed:author | pubmed-author:LaurentMM | lld:pubmed |
| pubmed-article:12297576 | pubmed:author | pubmed-author:GoodkinD EDE | lld:pubmed |
| pubmed-article:12297576 | pubmed:author | pubmed-author:EdanGG | lld:pubmed |
| pubmed-article:12297576 | pubmed:author | pubmed-author:MauckJJ | lld:pubmed |
| pubmed-article:12297576 | pubmed:author | pubmed-author:HartungH PHP | lld:pubmed |
| pubmed-article:12297576 | pubmed:author | pubmed-author:ButineM DMD | lld:pubmed |
| pubmed-article:12297576 | pubmed:author | pubmed-author:GhalieR GRG | lld:pubmed |
| pubmed-article:12297576 | pubmed:author | pubmed-author:EisenmanSS | lld:pubmed |
| pubmed-article:12297576 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:12297576 | pubmed:day | 24 | lld:pubmed |
| pubmed-article:12297576 | pubmed:volume | 59 | lld:pubmed |
| pubmed-article:12297576 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:12297576 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:12297576 | pubmed:pagination | 909-13 | lld:pubmed |
| pubmed-article:12297576 | pubmed:dateRevised | 2007-11-15 | lld:pubmed |
| pubmed-article:12297576 | pubmed:meshHeading | pubmed-meshheading:12297576... | lld:pubmed |
| pubmed-article:12297576 | pubmed:meshHeading | pubmed-meshheading:12297576... | lld:pubmed |
| pubmed-article:12297576 | pubmed:meshHeading | pubmed-meshheading:12297576... | lld:pubmed |
| pubmed-article:12297576 | pubmed:meshHeading | pubmed-meshheading:12297576... | lld:pubmed |
| pubmed-article:12297576 | pubmed:meshHeading | pubmed-meshheading:12297576... | lld:pubmed |
| pubmed-article:12297576 | pubmed:meshHeading | pubmed-meshheading:12297576... | lld:pubmed |
| pubmed-article:12297576 | pubmed:meshHeading | pubmed-meshheading:12297576... | lld:pubmed |
| pubmed-article:12297576 | pubmed:meshHeading | pubmed-meshheading:12297576... | lld:pubmed |
| pubmed-article:12297576 | pubmed:meshHeading | pubmed-meshheading:12297576... | lld:pubmed |
| pubmed-article:12297576 | pubmed:meshHeading | pubmed-meshheading:12297576... | lld:pubmed |
| pubmed-article:12297576 | pubmed:meshHeading | pubmed-meshheading:12297576... | lld:pubmed |
| pubmed-article:12297576 | pubmed:meshHeading | pubmed-meshheading:12297576... | lld:pubmed |
| pubmed-article:12297576 | pubmed:meshHeading | pubmed-meshheading:12297576... | lld:pubmed |
| pubmed-article:12297576 | pubmed:meshHeading | pubmed-meshheading:12297576... | lld:pubmed |
| pubmed-article:12297576 | pubmed:meshHeading | pubmed-meshheading:12297576... | lld:pubmed |
| pubmed-article:12297576 | pubmed:meshHeading | pubmed-meshheading:12297576... | lld:pubmed |
| pubmed-article:12297576 | pubmed:meshHeading | pubmed-meshheading:12297576... | lld:pubmed |
| pubmed-article:12297576 | pubmed:meshHeading | pubmed-meshheading:12297576... | lld:pubmed |
| pubmed-article:12297576 | pubmed:year | 2002 | lld:pubmed |
| pubmed-article:12297576 | pubmed:articleTitle | Cardiac adverse effects associated with mitoxantrone (Novantrone) therapy in patients with MS. | lld:pubmed |
| pubmed-article:12297576 | pubmed:affiliation | Immunex Corp., Seattle, WA 98101, USA. | lld:pubmed |
| pubmed-article:12297576 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:12297576 | pubmed:publicationType | Comparative Study | lld:pubmed |
| pubmed-article:12297576 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| pubmed-article:12297576 | pubmed:publicationType | Meta-Analysis | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12297576 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12297576 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12297576 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12297576 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12297576 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12297576 | lld:pubmed |
